- Report
- December 2022
- 142 Pages
Global
From €3981EUR$4,450USD£3,500GBP
- Report
- December 2019
- 120 Pages
Global
From €3310EUR$3,700USD£2,910GBP
- Report
- July 2025
- 200 Pages
India
From €2495EUR$2,789USD£2,194GBP
- Report
- June 2025
- 250 Pages
India
From €2495EUR$2,789USD£2,194GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2495EUR$2,789USD£2,194GBP
- Report
- June 2025
- 250 Pages
Mexico
From €2495EUR$2,789USD£2,194GBP
- Report
- June 2025
- 250 Pages
Vietnam
From €2495EUR$2,789USD£2,194GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2495EUR$2,789USD£2,194GBP
- Report
- June 2025
- 250 Pages
Japan
From €2495EUR$2,789USD£2,194GBP
- Report
- April 2023
- 147 Pages
Global
From €4427EUR$4,949USD£3,893GBP
- Report
- June 2024
- 183 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- July 2023
- 115 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- May 2023
- 147 Pages
Global
From €4427EUR$4,949USD£3,893GBP
- Report
- September 2024
- 304 Pages
United States
From €2325EUR$2,599USD£2,044GBP
- Report
- March 2024
- 249 Pages
Global
€4469EUR$4,995USD£3,929GBP
- Report
- March 2024
- 197 Pages
Global
€4469EUR$4,995USD£3,929GBP
- Report
- January 2024
- 250 Pages
Global
€4469EUR$4,995USD£3,929GBP
- Report
- July 2024
- 151 Pages
Global
From €3232EUR$3,613USD£2,841GBP
€3802EUR$4,250USD£3,343GBP
- Report
- October 2024
- 55 Pages
Global
From €2237EUR$2,500USD£1,966GBP
- Report
- December 2023
- 76 Pages
Global
From €890EUR$995USD£783GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more